20 Best Low Volatility Stocks to Buy According to Analysts

Page 8 of 20

13. AbbVie Inc. (NYSE:ABBV)

Analyst Upside: 10.92%

Beta Value: 0.50

Number of Hedge Fund Holders: 86

AbbVie Inc. (NYSE:ABBV) ranks among the best low volatility stocks to buy according to analysts. Ahead of the company’s second-quarter earnings report, JPMorgan reaffirmed its Overweight rating and $200 price target on AbbVie Inc. (NYSE:ABBV) on July 10.

Citing ongoing strength from Skyrizi and Rinvoq products as well as slight foreign exchange tailwinds that could result in another guidance raise, the firm expects AbbVie Inc. (NYSE:ABBV) to be well-positioned heading into the results. JPMorgan’s quarterly projections, which predict $15 billion in sales and $2.87 in earnings per share, are in line with market consensus.

According to JPMorgan, AbbVie Inc. (NYSE:ABBV) is in a solid spot as it won’t lose any significant exclusivity events until the mid-2030s, Moveover, the firm states that Skyrizi and Rinvoq can grow further, while the financial sheet has room for more business development to meet growth demands in the 2030s.

AbbVie Inc. (NYSE:ABBV) is a biopharmaceutical company that specializes in developing, manufacturing, and marketing therapies for complicated and chronic illnesses. Its next-generation immunology medications, Rinvoq and Skyrizi, continue to drive growth.

Page 8 of 20